Status:
UNKNOWN
Treatment of Common Bile Duct Stones
Lead Sponsor:
Tongji Hospital
Conditions:
Common Bile Duct Stone
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
ABSTRACT Introduction: Common bile duct (CBD) stone is a common clinical situation, especially in Asia area. Laparotomy and laparoscopic surgical procedure are often used for treatment. This study com...
Eligibility Criteria
Inclusion
- Patients with age between 18 - 80 years.
- Patients diagnosed with gallstones.
- Patients diagnosed with common bile duct stone by one of the three exam (US、MRCP and CT).
- Patients diagnosed with common bile duct stone by intro-operative cholangiography or transcystic exploration.
- Patients understood the trial and accepted one of the three managements.
Exclusion
- Combined with Mirizzi syndrome and intrahepatic bile duct stones
- Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD)
- History of upper abdominal surgery.
- Serious heart, brain, lung, metabolic diseases history.
- Pregnant women.
- Unwillingness or inability to consent for the study.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03442205
Start Date
March 1 2018
End Date
March 1 2021
Last Update
March 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430000